• A1 vs. AMD3100: Advancing CXCR4 Inhibition in Colorectal Can

  2026-05-13

  Khorramdelazad et al. introduce A1, a new fluorinated CXCR4 inhibitor, that demonstrates greater efficacy than AMD3100 in preclinical colorectal cancer models. Their integrated computational, cellular, and animal data reveal A1’s superior binding and anti-tumor effects, providing a benchmark for future research on CXCR4 axis-targeted therapies.

• Plant Nanovesicles Mitigate Testicular Injury via Sertoli Ce

  2026-05-13

  This study demonstrates that plant-derived exosome-like nanovesicles from Cistanche deserticola (CDELNs) can alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings reveal a novel cross-kingdom regulatory mechanism involving miR159b-3p, offering promising avenues for male reproductive protection.

• SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis

  2026-05-12

  This study demonstrates that pharmacological inhibition of SMYD2, notably using AZ505, mitigates renal fibrosis and inflammation in cisplatin-induced chronic kidney disease (CKD) models. The findings highlight SMYD2 as a critical epigenetic regulator and a promising therapeutic target for renal fibrosis, with implications for both mechanistic research and translational applications.

• Sulfaphenazole: Redefining CYP2C9 Inhibition for Translation

  2026-05-12

  This thought-leadership article explores how Sulfaphenazole, a selective CYP2C9 inhibitor, delivers translational value across vascular injury, drug metabolism research, and anti-infective strategies. By linking mechanistic understanding to recent in vivo breakthroughs and offering strategic guidance for protocol optimization, it positions Sulfaphenazole as an essential tool for researchers seeking to bridge preclinical insights and clinical innovation.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-05-11

  Vacuolin-1 enables selective, robust inhibition of Ca2+-dependent lysosomal exocytosis, empowering researchers to dissect membrane trafficking and repair pathways with confidence. Applied protocols and troubleshooting strategies maximize data quality in disease modeling and membrane repair assays.

• Mecamylamine Hydrochloride: Precision in Gut-Brain nAChR Res

  2026-05-11

  Explore how Mecamylamine hydrochloride empowers next-generation studies of gut-brain cholinergic signaling and neuropsychiatric disorder models. This guide details actionable protocols, troubleshooting strategies, and the translational impact inspired by landmark research on microbiota-mediated neural circuits.

• Z-DEVD-FMK: Caspase-3 Inhibitor Workflows for Apoptosis & Ne

  2026-05-10

  Z-DEVD-FMK, a robust caspase-3 inhibitor from APExBIO, empowers precise modulation of apoptosis and neuroprotection assays. This article guides researchers through optimized protocols, troubleshooting, and translational insights, drawing on recent advances in cell death modeling and melanoma research.

• X-Gal in Advanced Assay Design: Precision, Pitfalls, and Pra

  2026-05-09

  Explore the multifaceted role of X-Gal in molecular cloning and β-galactosidase assays, with a technical focus on assay design, troubleshooting, and mechanistic nuances. Discover how high-purity X-Gal enables next-generation blue-white screening and informed experimental decisions.

• RP3-340N1.2 Knockdown Modulates IL-6 in NSCLC Progression

  2026-05-08

  This study identifies the lncRNA RP3-340N1.2 as a driver of non-small cell lung cancer (NSCLC) malignancy via stabilization of IL-6 mRNA. Knockdown of RP3-340N1.2 not only suppresses tumor cell proliferation and migration but also enhances IL-6 mRNA degradation through ZC3H12A interaction, highlighting a promising therapeutic target for NSCLC intervention.

• Reversine: Aurora Kinase Inhibitor for Cancer Workflow Maste

  2026-05-08

  Leverage Reversine for precision inhibition of Aurora kinases in advanced cancer models and stem cell research. Discover hands-on protocols, troubleshooting insight, and new high-throughput applications—guided by the latest in microraft array technology and APExBIO’s trusted expertise.

• Dronedarone (Multaq): Innovations in Atrial Fibrillation Res

  2026-05-07

  Explore the advanced pharmacological profile of Dronedarone (Multaq) in atrial fibrillation research. This article uniquely connects molecular mechanisms, assay optimization, and evidence-based insights to empower scientific discovery.

• Ionizing Radiation Alters Neural Differentiation via PI3K-ST

  2026-05-07

  This study demonstrates that ionizing radiation (IR) can induce altered neuronal differentiation in C17.2 mouse neural stem-like cells via the PI3K-STAT3-mGluR1 signaling axis. These findings provide mechanistic insight into how IR may contribute to neural dysfunction, highlighting key molecular checkpoints relevant for neural stem cell research and radiotherapy side effect mitigation.

• Olive Biophenols Attenuate Alzheimer’s Pathology In Vitro an

  2026-05-06

  Omar et al. demonstrate that olive biophenols, particularly oleuropein, significantly inhibit amyloid beta aggregation and neurotoxicity in SH-SY5Y cells and APPswe/PS1dE9 mice. This work provides evidence for the disease-modifying potential of natural biophenols in Alzheimer’s models, supporting further exploration of plant-derived compounds as safer alternatives to synthetic inhibitors.

• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-05-06

  This study uncovers how elevated cholesterol within lipid nanoparticles (LNPs) disrupts their intracellular trafficking, leading to inefficient delivery of nucleic acid cargo. By combining a biotin-streptavidin tracking platform with high-throughput imaging, the research links cholesterol content directly to endosomal entrapment and reduced nucleic acid release.

• Cy5 TSA Fluorescence System Kit: Amplifying Detection Sensit

  2026-05-05

  Unlock ultrasensitive detection of low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization using the Cy5 TSA Fluorescence System Kit. This APExBIO solution empowers researchers with rapid workflow, robust specificity, and powerful signal amplification for even the most challenging targets.

16757 records 1/1118 page Next 12345 下5页 Last page